Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CHMP2B Antikörper (AA 1-213)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch CHMP2B in ELISA und IHC. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7147523

Kurzübersicht für CHMP2B Antikörper (AA 1-213) (ABIN7147523)

Target

Alle CHMP2B Antikörper anzeigen
CHMP2B (Charged Multivesicular Body Protein 2B (CHMP2B))

Reaktivität

  • 36
  • 33
  • 17
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 47
  • 3
  • 2
Kaninchen

Klonalität

  • 46
  • 6
Polyklonal

Konjugat

  • 26
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CHMP2B Antikörper ist unkonjugiert

Applikation

  • 43
  • 15
  • 14
  • 13
  • 13
  • 8
  • 7
  • 5
  • 3
  • 3
  • 3
  • 1
  • 1
ELISA, Immunohistochemistry (IHC)
  • Bindungsspezifität

    • 15
    • 9
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    AA 1-213

    Kreuzreaktivität

    Human

    Aufreinigung

    Antigen Affinity Purified

    Immunogen

    Recombinant Human Charged multivesicular body protein 2b protein (1-213AA)

    Isotyp

    IgG
  • Applikationshinweise

    Recommended dilution: IHC:1:20-1:200,

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    CHMP2B (Charged Multivesicular Body Protein 2B (CHMP2B))

    Andere Bezeichnung

    CHMP2B

    Hintergrund

    Background: Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4.

    Aliases: ALS17 antibody, Charged multivesicular body protein 2b antibody, CHM2B_HUMAN antibody, CHMP family, member 2B antibody, CHMP2.5 antibody, CHMP2b antibody, Chromatin modifying protein 2b antibody, Chromatin-modifying protein 2b antibody, DMT1 antibody, hVps2-2 antibody, Vacuolar protein sorting 2, yeast, homolog of, B antibody, Vacuolar protein sorting 2-2 antibody, Vacuolar protein sorting-associated protein 2-2 antibody, VPS2 homolog B antibody, Vps2-2 antibody, VPS2B antibody

    UniProt

    Q9UQN3
Sie sind hier:
Chat with us!